SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-24-100885
Filing Date
2024-04-18
Accepted
2024-04-18 16:56:32
Documents
11
Effectiveness Date
2024-04-18

Document Format Files

Seq Description Document Type Size
1 S-8 d793872ds8.htm S-8 190096
2 EX-5.1 d793872dex51.htm EX-5.1 9045
3 EX-23.1 d793872dex231.htm EX-23.1 1295
4 EX-99.1 d793872dex991.htm EX-99.1 100652
5 EX-99.2 d793872dex992.htm EX-99.2 58590
6 EX-99.3 d793872dex993.htm EX-99.3 100388
7 EX-FILING FEES d793872dexfilingfees.htm EX-FILING FEES 23057
8 GRAPHIC g793872dsp68_a.jpg GRAPHIC 4749
9 GRAPHIC g793872dsp68_b.jpg GRAPHIC 3521
10 GRAPHIC g793872g0418000901042.jpg GRAPHIC 2959
11 GRAPHIC g793872g0418001632729.jpg GRAPHIC 2533
  Complete submission text file 0001193125-24-100885.txt   503844
Mailing Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103
Business Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103 (415) 754-3517
Nuvation Bio Inc. (Filer) CIK: 0001811063 (see all company filings)

IRS No.: 850862255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-278804 | Film No.: 24854890
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)